作者：
Daniel J,Merk [1]
;
Linda,Paul [2]
;
Foteini,Tsiami [1]
;
Helen,Hohenthanner [2]
;
Ghazal Mohseni,Kouchesfahani [1]
;
Lara A,Haeusser [2]
;
Bianca,Walter [1]
;
Adam,Brown [2]
;
Nicole S,Persky [1]
;
David E,Root [2]
;
Ghazaleh,Tabatabai [1]
作者单位：
Department of Neurology and Interdisciplinary Neuro-Oncology, Hertie Institute for Clinical Brain Research, University Hospital Tübingen, Eberhard Karls University Tübingen, Tübingen, 72076, Germany.
[1]
Cluster of Excellence iFIT (EXC 2180) "Image Guided and Functionally Instructed Tumor Therapies", Eberhard Karls University Tübingen, Tübingen, 72076, Germany.
[2]
German Consortium for Translational Cancer Research (DKTK), Partner Site Tübingen, German Cancer Research Center (DKFZ), Heidelberg, 69120, Germany.
[3]
Genetic Perturbation Platform, Broad Institute of MIT and Harvard, Cambridge, MA, 02142, USA.
[4]
Department of Neurology and Interdisciplinary Neuro-Oncology, Hertie Institute for Clinical Brain Research, University Hospital Tübingen, Eberhard Karls University Tübingen, Tübingen, 72076, Germany. ghazaleh.tabatabai@uni-tuebingen.de.
[5]
Cluster of Excellence iFIT (EXC 2180) "Image Guided and Functionally Instructed Tumor Therapies", Eberhard Karls University Tübingen, Tübingen, 72076, Germany. ghazaleh.tabatabai@uni-tuebingen.de.
[6]
German Consortium for Translational Cancer Research (DKTK), Partner Site Tübingen, German Cancer Research Center (DKFZ), Heidelberg, 69120, Germany. ghazaleh.tabatabai@uni-tuebingen.de.
[7]
Comprehensive Cancer Center Tübingen-Stuttgart, University Hospital Tübingen, Eberhard Karls University Tübingen, Tübingen, 72076, Germany. ghazaleh.tabatabai@uni-tuebingen.de.
[8]
DOI
10.1186/s13073-024-01341-4
PMID
38886809
发布时间
2024-07-08
换一批
换一批
